hotspot -WSS

hotspot

author：fashion 2025-10-04 11:35:40 - browse：54853

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Galapagos to make CAR

leisure time

WSS

H5N1 bird flu found in pasteurized milk: what we know

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Diversity in clinical trials starts with building trust, experts say

ALS treatment from Biogen, Ionis fails in study

Close Medicare's dangerous gaps in addiction treatment coverage

After traumatic brain injury, life support decisions can use more time

entertainment

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Abbott's new stent may help patients with peripheral artery disease

Heart attack and stroke risk calculators need revising

FTC falls short on scrutinizing hospital mergers, study says

Guidelines to prevent youth baseball injuries need more muscle

Supreme Court to hear if Covid misinformation is protected speech

The high cost of giving birth even with insurance

Ripples from Flovent's discontinuation is killing children with asthma

Bright Health sells Medicare Advantage business to Molina

After traumatic brain injury, life support decisions can use more time

hotspot

Melinda French Gates resigns from Gates Foundation

HHS suspends federal funding for EcoHealth Alliance

Cancer researcher Catriona Jamieson is sending tumors into space

STAT series 'Denied by AI' wins major journalism prizes

The United States must get value

Supreme Court to hear if Covid misinformation is protected speech

leisure time

leisure time

focus

focus